GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore O&G Ltd (SGX:1D8) » Definitions » YoY EBITDA Growth

Singapore O&G (SGX:1D8) YoY EBITDA Growth : -25.00% (As of Dec. 2021)


View and export this data going back to 2015. Start your Free Trial

What is Singapore O&G YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Singapore O&G's YoY EBITDA Growth for the quarter that ended in Dec. 2021 was -25.00%.

Singapore O&G's EBITDA per Share for the six months ended in Dec. 2021 was S$0.01.


Singapore O&G YoY EBITDA Growth Historical Data

The historical data trend for Singapore O&G's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore O&G YoY EBITDA Growth Chart

Singapore O&G Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
YoY EBITDA Growth
Get a 7-Day Free Trial -4.35 9.09 -75.00 366.67 -7.14

Singapore O&G Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -200.00 -20.00 300.00 16.67 -25.00

Singapore O&G YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Singapore O&G's YoY EBITDA Growth for the fiscal year that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (A: Dec. 2021 )
=(EBITDA per Share (A: Dec. 2021 )-EBITDA per Share (A: Dec. 2020 ))/ | EBITDA per Share (A: Dec. 2020 ) |
=(0.026-0.028)/ | 0.028 |
=-7.14 %

Singapore O&G's YoY EBITDA Growth for the quarter that ended in Dec. 2021 is calculated as:

YoY EBITDA Growth (Q: Dec. 2021 )
=(EBITDA per Share (Q: Dec. 2021 )-EBITDA per Share (Q: Dec. 2020 )) / | EBITDA per Share (Q: Dec. 2020 )) |
=(0.012-0.016)/ | 0.016 |
=-25.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Singapore O&G YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Singapore O&G's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore O&G (SGX:1D8) Business Description

Traded in Other Exchanges
N/A
Address
229 Mountbatten Road, No. 02-02 Mountbatten Square, Singapore, SGP, 398007
Singapore O&G Ltd is a Singapore based group of medical practioners dedicated to women's health and wellness in the obstetrics and gynaecology field. Its areas of specialisation are pregnancy care and delivery; the female reproductive system; gynaecological and breast cancer; skin and aesthetic treatments; and other ancillary medical services. The segments of the group are Obstetrics and Gynaecology, Cancer-related, Dermatology, Paediatrics and Corporate. It generates a majority of the revenue from the Obstetrics and Gynaecology Segment which relates to general obstetrics, labour and delivery, general gynaecology and surgery, female pelvic medicine, and urogynaecology and reconstructive surgery. All the operations of the organization are carried out in Singapore.

Singapore O&G (SGX:1D8) Headlines

No Headlines